SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052979
Filing Date
2020-11-10
Accepted
2020-11-10 16:17:16
Documents
51
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eq-10q_20200930.htm 10-Q 2196758
2 EX-31.1 eq-ex311_7.htm EX-31.1 15888
3 EX-31.2 eq-ex312_9.htm EX-31.2 15975
4 EX-32.1 eq-ex321_8.htm EX-32.1 7417
  Complete submission text file 0001564590-20-052979.txt   6375345

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT eq-20200930.xml EX-101.INS 1231324
6 XBRL TAXONOMY EXTENSION SCHEMA eq-20200930.xsd EX-101.SCH 43051
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eq-20200930_cal.xml EX-101.CAL 43244
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eq-20200930_def.xml EX-101.DEF 167639
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20200930_lab.xml EX-101.LAB 345235
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20200930_pre.xml EX-101.PRE 260106
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 201301339
SIC: 2834 Pharmaceutical Preparations